Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein i immunocomplexes in patients with definite Antiphospholipid Syndrome

Lupus

Volumn 21, Issue 7, 2012, Pages 784-786

  Banzato, A ^a   Frasson, R ^a   Acquasaliente, L ^a   Bison, E ^a   Bracco, A ^a   Denas, G ^a   Cuffaro, S ^a   Hoxha, A ^a   Ruffatti, A ^a   Iliceto, S ^a   De Filippis, V ^a   Pengo, V ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Antiphospholipid Syndrome; beta2 glycoprotein I; immunocomplexes

Indexed keywords

BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIBODY; ENOXAPARIN; FONDAPARINUX; HEPARIN; IMMUNOGLOBULIN G; PROTEIN G; SODIUM CHLORIDE;

AFFINITY CHROMATOGRAPHY; ANTIGEN ANTIBODY COMPLEX; ANTIPHOSPHOLIPID SYNDROME; CLINICAL ARTICLE; CONFERENCE PAPER; DISSOCIATION CONSTANT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE SPECTROSCOPY; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION;

ANTIGEN-ANTIBODY COMPLEX; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CASE-CONTROL STUDIES; HEPARIN; HUMANS;

EID: 84861561957     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312440347     Document Type: Conference Paper

References (18)

1. Sheng Y, Kandiah DA, Krilis SA. Beta2-glycoprotein I: target antigen for 'antiphospholipid' antibodies. Immunological and molecular aspects. Lupus. 1998 ; 7 Suppl. 2: S5 - S9
2. de Groot PG, Meijers JC. beta(2)-Glycoprotein I: evolution, structure and function. J Thromb Haemost. 2011 ; 9: 1275-1284
3. de Groot PG. Mechanisms of anti-phospholipid antibody formation and action. Thromb Res. 2011 ; 127 Suppl. 3: S40 - S42
4. de Laat B, van Berkel M, Urbanus RT, et al. Immune responses against domain I of beta(2)glycoprotein I are driven by conformational changes: Domain I of beta(2)-glycoprotein I harbors a cryptic immunogenic epitope. Arthritis Rheum. 2011 ; 63: 3960-3968
5. Banzato A, Pozzi N, Frasson R, et al. Antibodies to Domain I of beta(2)Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS). Thromb Res. 2011 ; 128: 583-586
6. Tripodi A, de Groot PG, Pengo V. Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment. J Intern Med. 2011 ; 270: 110-122
7. Chudasama SL, Espinasse B, Hwang F, et al. Heparin modifies the immunogenicity of positively charged proteins. Blood. 2010 ; 116: 6046-6053
8. Pengo V, Biasiolo A, Pegoraro C, et al. A two-step coagulation test to identify antibeta-glycoprotein I lupus anticoagulants. J Thromb Haemost. 2004 ; 2: 702-707
9. Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2009 ; 7: 1737-1740
10. Biasiolo A, Pengo V. Antiphospholipid antibodies are not present in the membrane of gel-filtered platelets of patients with IgG anticardiolipin antibodies, lupus anticoagulant and thrombosis. Blood Coagul Fibrinolysis. 1993 ; 4: 425-428
11. Tincani A, Allegri F, Balestrieri G, et al. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res. 2004 ; 114: 553-558
12. Pengo V, Biasiolo A, Fior MG. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface. Thromb Haemost. 1995 ; 73: 29-34
13. Reber G, Tincani A, Sanmarco M, et al. Proposals for the measurement of anti-beta2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost. 2004 ; 2: 1860-1862
14. Pozzi N, Banzato A, Bettin S, et al. Chemical synthesis and characterization of wild-type and biotinylated N-terminal domain 1-64 of beta2-glycoprotein I. Prot Sc. 2010 ; 19: 1065-1078
15. Pengo V, Biasiolo A, Bison E, et al. Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity. Thromb Res. 2007 ; 120: 127-133
16. De Filippis V, Frasson R, Fontana A. 3-Nitrotyrosine as a spectroscopic probe for investigating protein-protein interactions. Prot Sci. 2006 ; 15: 976-986
17. Gresele P, Migliacci R, Vedovati MC, et al. Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function. Thromb Res. 2009 ; 123: 444-451
18. de Laat B, Mertens K, de Groot PG. Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism. Nat Clin Pract Rheumatol. 2008 ; 4: 192-199